4WZ6 | Human CFTR aa389-678 (NBD1), deltaF508 with three solubilizing mutations, bound ATP | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Byrnes, L.J., Hall, J. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.05 | ||||||||||||
ligand | ATP, MG | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy., Hall JD, Wang H, Byrnes LJ, Shanker S, Wang K, Efremov IV, Chong PA, Forman-Kay JD, Aulabaugh AE, Protein Sci. 2016 Feb;25(2):360-73. doi: 10.1002/pro.2821. Epub 2016 Jan 12. PMID:26444971 |
Data retrieval |
View 4WZ6 in 3D |
Visual 3D analysis of 4WZ6 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4WZ6 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |